» Articles » PMID: 32445749

TNF-α (rs1800629) Polymorphism Modifies the Effect of Sensitization to House Dust Mite on Asthma and Bronchial Hyperresponsiveness in Children

Overview
Journal Exp Mol Pathol
Publisher Elsevier
Date 2020 May 24
PMID 32445749
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a complex disease, with various genetic and environmental factors implicated in its development. Sensitization to the house dust mite (HDM) is closely linked with the development of respiratory allergies, including asthma. However, some children sensitized to HDM do not complain of any symptoms of respiratory allergies, even though HDM is correlated with an increased risk for developing asthma, suggesting the involvement of other factors. Tumor necrosis factor (TNF)-α is associated with the pathophysiologies of asthma in combination with its genetic polymorphism. The aim of the present study was to elucidate the associations between sensitization to HDM, polymorphism of TNF-α rs1800629, and asthma/bronchial hyperresponsiveness (BHR). Our results revealed that sensitization to HDM is associated with asthma diagnosis in lifetime, current asthma, and BHR in Korean children. Furthermore, the genetic polymorphism of TNF-a rs1800629 was found to modify and interact with these associations. This study suggests that prevention strategies for childhood asthma need to be targeted according to genetic susceptibility.

Citing Articles

Anti-Allergic and Anti-Inflammatory Effects of Lidocaine-Derived Organic Compounds in a House Dust Mite-Induced Allergic Rhinitis Mouse Model.

Shin S, Ye M, Chae M, Geum S, Aboraia A, Abdel-Aal A Biomedicines. 2024; 12(9).

PMID: 39335479 PMC: 11429074. DOI: 10.3390/biomedicines12091965.


Impact of Interleukin-17 Receptor A Gene Variants on Asthma Susceptibility and Clinical Manifestations in Children and Adolescents.

Maher S, AbdAllah N, Al Ageeli E, Riad E, Kattan S, Abdelaal S Children (Basel). 2024; 11(6).

PMID: 38929236 PMC: 11202101. DOI: 10.3390/children11060657.


How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March.

Jacques C, Floris I Int J Mol Sci. 2023; 24(2).

PMID: 36675006 PMC: 9864899. DOI: 10.3390/ijms24021483.